Glycaemic control was markedly improved by pioglitazone in a patient with type 2 diabetes mellitus associated with Charcot-Marie-Tooth disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1393, 2003-01, pp. : 13-13

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Vincristine: Peripheral nerve disorders in a patient with Charcot-Marie-Tooth disease type 2: case report

By  

Reactions Weekly, Vol. 1, Iss. 1215, 2008-01 ,pp. : 40-40

Adis International

Access to resources Recommend Favorite

LAF 237: improved glycaemic control in type 2 diabetes mellitus

By  

Inpharma, Vol. 1, Iss. 1451, 2004-01 ,pp. : 7-8

Adis International

Access to resources Recommend Favorite

Pioglitazone provides greater long-term glycaemic control than glibenclamide [glyburide] in patients with type 2 diabetes mellitus (T2DM)

By  

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus

By Britton M.E.   denver A.E.   Mohamed-Ali V.   Yudkin J.S.  

Clinical Drug Investigation, Vol. 16, Iss. 4, 1998-10 ,pp. : 303-317

Adis International

Access to resources Recommend Favorite

Vincristine: Exacerbation of polyneuropathy in Charcot-Marie-Tooth disease: case report

By  

Reactions Weekly, Vol. 1, Iss. 1416, 2012-01 ,pp. : 44-44

Adis International

Access to resources Recommend Favorite